References
[1] Haissaguerre M, Gencel L, Fischer B, Le Metayer P, Poquet F,
Marcus FI, Clementy J: Successful catheter ablation of atrial
fibrillation. J Cardiovasc Electrophysiol 1994; 5:1045-1052.
[2] Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou
G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J: Spontaneous
initiation of atrial fibrillation by ectopic beats originating in the
pulmonary veins. N Engl J Med 1998; 339:659-666.
[3] Piccini JP, Daubert JP: Cryoablation of atrial fibrillation. J
Interv Card Electrophysiol 2011; 32:233-242.
[4] Dukkipati SR, Neuzil P, Kautzner J, Petru J, Wichterle D, Skoda
J, Cihak R, Peichl P, Dello Russo A, Pelargonio G, Tondo C, Natale A,
Reddy VY: The durability of pulmonary vein isolation using the visually
guided laser balloon catheter: multicenter results of pulmonary vein
remapping studies. Heart Rhythm 2012; 9:919-925.
[5] Ullah W, McLean A, Tayebjee MH, Gupta D, Ginks MR, Haywood GA,
O’Neill M, Lambiase PD, Earley MJ, Schilling RJ, Group** UKMT:
Randomized trial comparing pulmonary vein isolation using the SmartTouch
catheter with or without real-time contact force data. Heart Rhythm
2016; 13:1761-1767.
[6] Kautzner J, Neuzil P, Lambert H, Peichl P, Petru J, Cihak R,
Skoda J, Wichterle D, Wissner E, Yulzari A, Kuck KH: EFFICAS II:
optimization of catheter contact force improves outcome of pulmonary
vein isolation for paroxysmal atrial fibrillation. Europace 2015;
17:1229-1235.
[7] Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L,
Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK,
Nielsen JC, Curtis AB, Davies DW, Day JD, d’Avila A, de Groot N, Di
Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst
S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek
E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH,
Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M,
Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K,
Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling
R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T: 2017
HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and
surgical ablation of atrial fibrillation. Heart Rhythm 2017;
14:e275-e444.
[8] Andrade JG, Monir G, Pollak SJ, Khairy P, Dubuc M, Roy D,
Talajic M, Deyell M, Rivard L, Thibault B, Guerra PG, Nattel S, Macle L:
Pulmonary vein isolation using ”contact force” ablation: the effect on
dormant conduction and long-term freedom from recurrent atrial
fibrillation–a prospective study. Heart Rhythm 2014; 11:1919-1924.
[9] Anter E, Contreras-Valdes FM, Shvilkin A, Tschabrunn CM,
Josephson ME: Acute pulmonary vein reconnection is a predictor of atrial
fibrillation recurrence following pulmonary vein isolation. J Interv
Card Electrophysiol 2014; 39:225-232.
[10] Anter E, Tschabrunn CM, Contreras-Valdes FM, Buxton AE,
Josephson ME: Radiofrequency ablation annotation algorithm reduces the
incidence of linear gaps and reconnection after pulmonary vein
isolation. Heart Rhythm 2014; 11:783-790.
[11] Haines DE: Cooking With Radiofrequency Energy: What Is the
Right Recipe? JACC Clin Electrophysiol 2018; 4:480-482.
[12] Nakagawa H, Wittkampf FH, Yamanashi WS, Pitha JV, Imai S,
Campbell B, Arruda M, Lazzara R, Jackman WM: Inverse relationship
between electrode size and lesion size during radiofrequency ablation
with active electrode cooling. Circulation 1998; 98:458-465.
[13] Bruce GK, Bunch TJ, Milton MA, Sarabanda A, Johnson SB, Packer
DL: Discrepancies between catheter tip and tissue temperature in
cooled-tip ablation: relevance to guiding left atrial ablation.
Circulation 2005; 112:954-960.
[14] Guy DJ, Boyd A, Thomas SP, Ross DL: Increasing power versus
duration for radiofrequency ablation with a high superfusate flow:
implications for pulmonary vein ablation? Pacing Clin Electrophysiol
2003; 26:1379-1385.
[15] Reddy VY, Dukkipati SR, Neuzil P, Natale A, Albenque JP,
Kautzner J, Shah D, Michaud G, Wharton M, Harari D, Mahapatra S, Lambert
H, Mansour M: Randomized, Controlled Trial of the Safety and
Effectiveness of a Contact Force-Sensing Irrigated Catheter for Ablation
of Paroxysmal Atrial Fibrillation: Results of the TactiCath Contact
Force Ablation Catheter Study for Atrial Fibrillation (TOCCASTAR) Study.
Circulation 2015; 132:907-915.
[16] Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F,
Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G,
Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA, ThermoCool AFTI:
Comparison of antiarrhythmic drug therapy and radiofrequency catheter
ablation in patients with paroxysmal atrial fibrillation: a randomized
controlled trial. JAMA 2010; 303:333-340.
[17] Natale A, Reddy VY, Monir G, Wilber DJ, Lindsay BD, McElderry
HT, Kantipudi C, Mansour MC, Melby DP, Packer DL, Nakagawa H, Zhang B,
Stagg RB, Boo LM, Marchlinski FE: Paroxysmal AF catheter ablation with a
contact force sensing catheter: results of the prospective, multicenter
SMART-AF trial. J Am Coll Cardiol 2014; 64:647-656.
[18] Itoh T, Kimura M, Tomita H, Sasaki S, Owada S, Horiuchi D,
Sasaki K, Ishida Y, Kinjo T, Okumura K: Reduced residual conduction gaps
and favourable outcome in contact force-guided circumferential pulmonary
vein isolation. Europace 2016; 18:531-537.
[19] Reddy VY, Pollak S, Lindsay BD, McElderry HT, Natale A,
Kantipudi C, Mansour M, Melby DP, Lakkireddy D, Levy T, Izraeli D,
Sangli C, Wilber D: Relationship Between Catheter Stability and 12-Month
Success After Pulmonary Vein Isolation: A Subanalysis of the SMART-AF
Trial. JACC Clin Electrophysiol 2016; 2:691-699.
[20] Chinitz LA, Melby DP, Marchlinski FE, Delaughter C, Fishel RS,
Monir G, Patel AM, Gibson DN, Athill CA, Ming Boo L, Stagg R, Natale A:
Safety and efficiency of porous-tip contact-force catheter for
drug-refractory symptomatic paroxysmal atrial fibrillation ablation:
results from the SMART SF trial. Europace 2018; 20:f392-f400.
[21] Leshem E, Zilberman I, Tschabrunn CM, Barkagan M,
Contreras-Valdes FM, Govari A, Anter E: High-Power and Short-Duration
Ablation for Pulmonary Vein Isolation: Biophysical Characterization.
JACC Clin Electrophysiol 2018; 4:467-479.
[22] Yuyun MF, Stafford PJ, Sandilands AJ, Samani NJ, Andre Ng G:
The impact of power output during percutaneous catheter radiofrequency
ablation for atrial fibrillation on efficacy and safety outcomes: a
systematic review. J Cardiovasc Electrophysiol 2013; 24:1216-1223.
[23] Reddy VY, Grimaldi M, De Potter T, Vijgen JM, Bulava A,
Duytschaever MF, Martinek M, Natale A, Knecht S, Neuzil P, Purerfellner
H: Pulmonary Vein Isolation With Very High Power, Short Duration,
Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC Clin
Electrophysiol 2019; 5:778-786.
[24] Haines DE: The biophysics of radiofrequency catheter ablation
in the heart: the importance of temperature monitoring. Pacing Clin
Electrophysiol 1993; 16:586-591.
[25] Bourier F, Duchateau J, Vlachos K, Lam A, Martin CA, Takigawa
M, Kitamura T, Frontera A, Cheniti G, Pambrun T, Klotz N, Denis A,
Derval N, Cochet H, Sacher F, Hocini M, Haissaguerre M, Jais P:
High-power short-duration versus standard radiofrequency ablation:
Insights on lesion metrics. J Cardiovasc Electrophysiol 2018;
29:1570-1575.
[26] Bhaskaran A, Chik W, Pouliopoulos J, Nalliah C, Qian P, Barry
T, Nadri F, Samanta R, Tran Y, Thomas S, Kovoor P, Thiagalingam A: Five
seconds of 50-60 W radio frequency atrial ablations were transmural and
safe: an in vitro mechanistic assessment and force-controlled in vivo
validation. Europace 2017; 19:874-880.
[27] Borne RT, Sauer WH, Zipse MM, Zheng L, Tzou W, Nguyen DT:
Longer Duration Versus Increasing Power During Radiofrequency Ablation
Yields Different Ablation Lesion Characteristics. JACC Clin
Electrophysiol 2018; 4:902-908.
[28] Ali-Ahmed F, Goyal V, Patel M, Orelaru F, Haines DE, Wong WS:
High-power, low-flow, short-ablation duration-the key to avoid
collateral injury? J Interv Card Electrophysiol 2019; 55:9-16.
[29] Kottmaier M, Popa M, Bourier F, Reents T, Cifuentes J, Semmler
V, Telishevska M, Otgonbayar U, Koch-Buttner K, Lennerz C, Bartkowiak M,
Kornmayer M, Rousseva E, Brkic A, Grebmer C, Kolb C, Hessling G,
Deisenhofer I: Safety and outcome of very high-power short-duration
ablation using 70 W for pulmonary vein isolation in patients with
paroxysmal atrial fibrillation. Europace 2020; 22:388-393.
[30] Vassallo F, Cunha C, Serpa E, Meigre LL, Carloni H, Simoes A,
Jr., Hespanhol D, Lovatto CV, Batista W, Jr., Serpa R: Comparison of
high-power short-duration (HPSD) ablation of atrial fibrillation using a
contact force-sensing catheter and conventional technique: Initial
results. J Cardiovasc Electrophysiol 2019; 30:1877-1883.
[31] Winkle RA, Mohanty S, Patrawala RA, Mead RH, Kong MH, Engel G,
Salcedo J, Trivedi CG, Gianni C, Jais P, Natale A, Day JD: Low
complication rates using high power (45-50 W) for short duration for
atrial fibrillation ablations. Heart Rhythm 2019; 16:165-169.
[32] Baher A, Kheirkhahan M, Rechenmacher SJ, Marashly Q, Kholmovski
EG, Siebermair J, Acharya M, Aljuaid M, Morris AK, Kaur G, Han FT,
Wilson BD, Steinberg BA, Marrouche NF, Chelu MG: High-Power
Radiofrequency Catheter Ablation of Atrial Fibrillation: Using Late
Gadolinium Enhancement Magnetic Resonance Imaging as a Novel Index of
Esophageal Injury. JACC Clin Electrophysiol 2018; 4:1583-1594.
[33] Matiello M, Mont L, Tamborero D, Berruezo A, Benito B, Gonzalez
E, Brugada J: Cooled-tip vs. 8 mm-tip catheter for circumferential
pulmonary vein ablation: comparison of efficacy, safety, and lesion
extension. Europace 2008; 10:955-960.
[34] Kanj MH, Wazni O, Fahmy T, Thal S, Patel D, Elayi C, Di Biase
L, Arruda M, Saliba W, Schweikert RA, Cummings JE, Burkhardt JD, Martin
DO, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Potenza D,
Fanelli R, Massaro R, Forleo G, Natale A: Pulmonary vein antral
isolation using an open irrigation ablation catheter for the treatment
of atrial fibrillation: a randomized pilot study. J Am Coll Cardiol
2007; 49:1634-1641.
[35] Nilsson B, Chen X, Pehrson S, Svendsen JH: The effectiveness of
a high output/short duration radiofrequency current application
technique in segmental pulmonary vein isolation for atrial fibrillation.
Europace 2006; 8:962-965.
[36] Yamada T, Murakami Y, Okada T, Okamoto M, Shimizu T, Toyama J,
Yoshida Y, Tsuboi N, Ito T, Muto M, Kondo T, Inden Y, Hirai M, Murohara
T: Can segmental pulmonary vein ablation reduce the recurrence of atrial
fibrillation when using a higher RF power, larger tip electrode
catheter, and additional RF deliveries?: the limitations of
point-by-point RF ablation. Int Heart J 2006; 47:219-228.
[37] Mansour M, Ruskin J, Keane D: Efficacy and safety of segmental
ostial versus circumferential extra-ostial pulmonary vein isolation for
atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15:532-537.
[38] Haissaguerre M, Jais P, Shah DC, Garrigue S, Takahashi A,
Lavergne T, Hocini M, Peng JT, Roudaut R, Clementy J:
Electrophysiological end point for catheter ablation of atrial
fibrillation initiated from multiple pulmonary venous foci. Circulation
2000; 101:1409-1417.
[39] Yavin HD, Leshem E, Shapira-Daniels A, Sroubek J, Barkagan M,
Haffajee CI, Cooper JM, Anter E: Impact of High-Power Short-Duration
Radiofrequency Ablation on Long-Term Lesion Durability for Atrial
Fibrillation Ablation. JACC: Clinical Electrophysiology 2020:1154.
[40] Winkle RA, Moskovitz R, Hardwin Mead R, Engel G, Kong MH,
Fleming W, Salcedo J, Patrawala RA, Tranter JH, Shai I: Atrial
fibrillation ablation using very short duration 50 W ablations and
contact force sensing catheters. J Interv Card Electrophysiol 2018;
52:1-8.
[41] Winkle RA, Mead RH, Engel G, Patrawala RA: Atrial fibrillation
ablation: ”perpetual motion” of open irrigated tip catheters at 50 W is
safe and improves outcomes. Pacing Clin Electrophysiol 2011; 34:531-539.
[42] Dixit S, Gerstenfeld EP, Callans DJ, Cooper JM, Lin D, Russo
AM, Verdino RJ, Patel VV, Kimmel SE, Ratcliffe SJ, Hsia HH, Nayak HM,
Zado E, Ren JF, Marchlinski FE: Comparison of cool tip versus 8-mm tip
catheter in achieving electrical isolation of pulmonary veins for
long-term control of atrial fibrillation: a prospective randomized pilot
study. J Cardiovasc Electrophysiol 2006; 17:1074-1079.
[43] Castrejon-Castrejon S, Martinez Cossiani M, Ortega Molina M,
Escobar C, Froilan Torres C, Gonzalo Bada N, Diaz de la Torre M, Suarez
Parga JM, Lopez Sendon JL, Merino JL: Feasibility and safety of
pulmonary vein isolation by high-power short-duration radiofrequency
application: short-term results of the POWER-FAST PILOT study. J Interv
Card Electrophysiol 2020; 57:57-65.
[44] Medi C, Evered L, Silbert B, Teh A, Halloran K, Morton J,
Kistler P, Kalman J: Subtle post-procedural cognitive dysfunction after
atrial fibrillation ablation. J Am Coll Cardiol 2013; 62:531-539.
[45] Hwang ES, Pak HN, Park SW, Park JS, Joung B, Choi D, Lee MH,
Kim YH: Risks and benefits of an open irrigation tip catheter in
intensive radiofrequency catheter ablation in patients with
non-paroxysmal atrial fibrillation. Circ J 2010; 74:644-649.
[46] Bunch TJ, Day JD: Novel ablative approach for atrial
fibrillation to decrease risk of esophageal injury. Heart Rhythm 2008;
5:624-627.
[47] Das M, Loveday JJ, Wynn GJ, Gomes S, Saeed Y, Bonnett LJ,
Waktare JEP, Todd DM, Hall MCS, Snowdon RL, Modi S, Gupta D: Ablation
index, a novel marker of ablation lesion quality: prediction of
pulmonary vein reconnection at repeat electrophysiology study and
regional differences in target values. Europace 2017; 19:775-783.
[48] Armstrong RB: Magnitude and distribution of muscle blood flow
in conscious animals during locomotory exercise. Med Sci Sports Exerc
1988; 20:S119-123.
[49] Hsu LF, Jais P, Hocini M, Sanders P, Scavee C, Sacher F,
Takahashi Y, Rotter M, Pasquie JL, Clementy J, Haissaguerre M: Incidence
and prevention of cardiac tamponade complicating ablation for atrial
fibrillation. Pacing Clin Electrophysiol 2005; 28 Suppl 1:S106-109.
[50] Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A,
Bhargava M, Saad E, Bash D, Yamada H, Jaber W, Schweikert R, Tchou P,
Abdul-Karim A, Saliba W, Natale A: Phased-array intracardiac
echocardiography monitoring during pulmonary vein isolation in patients
with atrial fibrillation: impact on outcome and complications.
Circulation 2003; 107:2710-2716.
[51] Iwasawa J, Koruth JS, Petru J, Dujka L, Kralovec S, Mzourkova
K, Dukkipati SR, Neuzil P, Reddy VY: Temperature-Controlled
Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With
Atrial Fibrillation. J Am Coll Cardiol 2017; 70:542-553.